Naturally Splendid Closes Private Placement, Secures Laboratory Facility

— Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed its non-brokered private placement financing for a total of 15,887,503 units (the “Units”) at $0.06 per Unit, for total gross proceeds of $1,053,250 (the “Offering”). Due to oversubscribed demand, the private placement financing was increased from 14,166,667 Units to 17,554,167.Continue reading “Naturally Splendid Closes Private Placement, Secures Laboratory Facility”

1933 Industries Closes Non-Brokered Private Placement and Provides Corporate Update

 Vancouver, Canada – 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company with a diverse portfolio of consumer-driven brands, announces that it has closed its private placement originally announced on July 17, 2020, with the issuance of 10,510,040 Units at a price of $0.075 per Unit for gross proceedsContinue reading “1933 Industries Closes Non-Brokered Private Placement and Provides Corporate Update”

Indiva Announces Closing of Private Placement of Units

Announces Prairie Merchant Participates in Offering and Becomes Insider; Provides Early Warning Report — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce that further to its news releases dated June 26, 2020 and July 9, 2020, it has closed theContinue reading “Indiva Announces Closing of Private Placement of Units”

Nutritional High Announces Closing of Psychedelic Science Corp’s Private Placement of Units

– Nutritional High International Inc. (CSE: EAT) (“Nutritional High” or, the “Company“) is pleased to announce that Psychedelic Science Corp. (“PSC“) has closed a non-brokered private placement (the “Offering“) for aggregate gross proceeds of $1,035,689 through the issuance 34,522,968 units (the “Units“) of PSC at a price of $0.03 per Unit. Each Unit is comprised ofContinue reading “Nutritional High Announces Closing of Psychedelic Science Corp’s Private Placement of Units”

1933 Industries Announces Leadership Changes

Mr. Paul Rosen named Interim CEO Mr. Eugene Ruiz named President New leadership to focus on accelerating growth and profitability – 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company, announces the appointments of Mr. Paul Rosen as Interim CEO and Mr. Eugene Ruiz as President, effective immediately, to guide the strategic direction ofContinue reading “1933 Industries Announces Leadership Changes”

Amended: Naturally Splendid Closes Private Placement

“Prior to COVID-19, the plant-based food category was growing at a rate outpacing traditional food channels and we expect this trend to continue post-pandemic times.” Naturally Splendid Enterprises Ltd. (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed its non-brokered private placement financing for a total of 42,857,159 units (the “Units”) at $0.035Continue reading “Amended: Naturally Splendid Closes Private Placement”

Core One Labs Announces Private Placement Financing and Non-Binding Letter of Intent to Acquire Medical Clinics

Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) (the “Company“) is pleased to announce that it has entered into a non-binding letter of intent (the “Letter of Intent“), dated June 4, 2020, with Rejuva Alternative Medicine Research Centre Inc. (“Rejuva“) and Shahcor Health Services Inc. (“Shahcor“), pursuant to which the Company proposesContinue reading “Core One Labs Announces Private Placement Financing and Non-Binding Letter of Intent to Acquire Medical Clinics”

MediPharm Labs Closes $37.8 Million Private Placement

“excited about the global market opportunity and leveraging our multi-jurisdictional pharmaceutical-quality manufacturing platform in a nascent cannabis market.” MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that it has today closed a private placement with an institutional investorContinue reading “MediPharm Labs Closes $37.8 Million Private Placement”

FSD Pharma Inc. Announces C$10.125 Million Private Placement

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (“FSD Pharma” or the “Company”), today announced it has entered into definitive agreements with certain institutional investors for the purchase and sale of 1,500,000 shares of the Company’s Class B Subordinate Voting Shares (“Shares”) at a price of C$6.75 per Share pursuant to a private placement resulting in grossContinue reading “FSD Pharma Inc. Announces C$10.125 Million Private Placement”